Facephi Biometria (XMAD:FACE) PE Ratio: 145.71 (As of Jun. 27, 2026) — 265% Above Median


XMAD:FACE Facephi Biometria SA XMAD:FACE
70 GF Score
Price €2.04
GF Value €2.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Facephi Biometria PE Ratio?

Facephi Biometria XMAD:FACE -1.45% 70 PE Ratio is 145.71 as of Jun. 27, 2026, which is 265% above its 10-year median of 39.92. GuruFocus rates XMAD:FACE with a GF Score™ of 70/100 and a GF Value™ of €2.91 (Significantly Undervalued). The stock has 3 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-27), Facephi Biometria's share price is €2.04. Facephi Biometria's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01. Therefore, Facephi Biometria's PE Ratio for today is 145.71.

Good Sign:

Facephi Biometria SA stock PE Ratio (=145.71) is close to 2-year low of 142.86.

During the past 13 years, Facephi Biometria's highest PE Ratio was 188.57. The lowest was 9.10. And the median was 39.92.

Facephi Biometria's EPS (Diluted) for the six months ended in Dec. 2025 was €0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

As of today (2026-06-27), Facephi Biometria's share price is €2.04. Facephi Biometria's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07. Therefore, Facephi Biometria's PE Ratio without NRI ratio for today is 30.45.

During the past 13 years, Facephi Biometria's highest PE Ratio without NRI was 57.16. The lowest was 9.10. And the median was 25.76.

Facephi Biometria's EPS without NRI for the six months ended in Dec. 2025 was €0.28. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.07.

During the past 3 years, the average EPS without NRI Growth Rate was -19.80% per year.

During the past 13 years, Facephi Biometria's highest 3-Year average EPS without NRI Growth Rate was 46.10% per year. The lowest was -135.60% per year. And the median was -19.80% per year.

Facephi Biometria's EPS (Basic) for the six months ended in Dec. 2025 was €0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.01.

Back to Basics: PE Ratio


Facephi Biometria  (XMAD:FACE) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Facephi Biometria PE Ratio Related Terms


Facephi Biometria PE Ratio Historical Data

* Premium members only.

The historical data trend for Facephi Biometria's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Facephi Biometria PE Ratio Chart

Facephi Biometria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss 39.06 At Loss At Loss 180.71

Facephi Biometria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 180.71

XMAD:FACE vs CRM, SHOP, UBER: PE Ratio Comparison

For the Software - Application subindustry, Facephi Biometria's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Facephi Biometria PE Ratio vs Software Industry

For the Software industry and Technology sector, Facephi Biometria's PE Ratio distribution charts can be found below:

* The bar in red indicates where Facephi Biometria's PE Ratio falls into.


XMAD:FACE
70GF Score
Facephi Biometria SA XMAD:FACE
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Facephi Biometria PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Facephi Biometria's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=2.04/0.014
=145.71

Facephi Biometria's Share Price of today is €2.04.
For company reported semi-annually, Facephi Biometria's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 145.71 mean?
Facephi Biometria (XMAD:FACE) has a PE Ratio of 145.71 as of Jun. 27, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Facephi Biometria and its competitors. This is 265% above median its historical median of 39.92. Over the past decade, Facephi Biometria's PE Ratio has ranged from 9.10 to 188.57.
Is Facephi Biometria's PE Ratio too high?
Facephi Biometria's current PE Ratio of 145.71 is 265% above median its 10-year median of 39.92. Over the past 10 years, this metric has ranged from a low of 9.10 to a high of 188.57. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's PE Ratio compare to CRM and SHOP?
Facephi Biometria's PE Ratio of 145.71 can be compared against companies in the Software industry. Historically, Facephi Biometria's own PE Ratio has ranged from 9.10 to 188.57 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Software company?
A good PE Ratio depends on the Software industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Facephi Biometria and its competitors. Facephi Biometria's current PE Ratio is 145.71, which is 265% above median its own 10-year median of 39.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.91, compared to a current price of €2.04 — trading 29.9% below its estimated fair value. The current PE Ratio is 145.71, which is 265% above median its 10-year median of 39.92. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current PE Ratio is 145.71 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?

Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued. The current stock price of €2.04 is trading 29.9% below its estimated GF Value™ of €2.91. GuruFocus considers Facephi Biometria to be Significantly Undervalued.

Key valuation signals for XMAD:FACE:

  • PE Ratio: 145.71 (265% above median its 10-year median of 39.92)
  • GF Value™: €2.91 vs. price of €2.04 (29.9% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Facephi Biometria Business Description

Other Exchanges ALPHI:France8FB:Germany
Address Avenida Perfecto Palacio de la Fuente, 6, Alicante, ESP, 03001
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score

Get the complete analysis for XMAD:FACE

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.04
Price
€2.91
GF Value